{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:36:08Z","timestamp":1790192168734,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009753","name":"School of Pharmacy, University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.japh.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:10:33Z","timestamp":1628395833000},"page":"370-377.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies"],"prefix":"10.1016","volume":"62","author":[{"given":"Rob","family":"Bellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-7600","authenticated-orcid":false,"given":"Sheila","family":"Mohebbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Nobahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Parizher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-0826","authenticated-orcid":false,"given":"Dorie E.","family":"Apollonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.japh.2021.08.001_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAI.0000000000001579","article-title":"Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States","volume":"77","author":"Mayer","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"5","key":"10.1016\/j.japh.2021.08.001_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178737","article-title":"Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention","volume":"12","author":"Patel","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.japh.2021.08.001_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/QAI.0000000000000403","article-title":"Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013","volume":"68","author":"Jain","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.japh.2021.08.001_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1521\/aeap.2015.27.4.289","article-title":"Awareness of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) is low but interest is high among men engaging in condomless anal sex with men in Boston, Pittsburgh, and San Juan","volume":"27","author":"Dolezal","year":"2015","journal-title":"AIDS Educ Prev"},{"issue":"1","key":"10.1016\/j.japh.2021.08.001_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1715163517745517","article-title":"Pharmacists as accessible primary health care providers: review of the evidence","volume":"151","author":"Tsuyuki","year":"2018","journal-title":"Can Pharm J (Ott)"},{"issue":"6","key":"10.1016\/j.japh.2021.08.001_bib15","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.japh.2020.06.005","article-title":"Attitudes about community pharmacy access to HIV prevention medications in California","volume":"60","author":"Koester","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2021.08.001_bib16","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1016\/j.japh.2020.09.020","article-title":"Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: a survey of patients receiving antiretroviral therapy","volume":"61","author":"Lutz","year":"2021","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2021.08.001_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1331\/JAPhA.2008.07138","article-title":"Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study","volume":"48","author":"Gardner","year":"2008","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"31","key":"10.1016\/j.japh.2021.08.001_bib18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.15585\/mmwr.mm6831e1","article-title":"Vital signs: pharmacy-based naloxone dispensing - United States, 2012\u20132018","volume":"68","author":"Guy","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.japh.2021.08.001_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1592\/phco.27.7.1040","article-title":"Tobacco interventions delivered by pharmacists: a summary and systematic review","volume":"27","author":"Dent","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.japh.2021.08.001_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1331\/154434506776180621","article-title":"Pharmacist involvement with immunizations: a decade of professional advancement [published correction appears in J Am Pharm Assoc (Wash DC). 2006;46(3):308]","volume":"46","author":"Hogue","year":"2006","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2021.08.001_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1472-6963-14-261","article-title":"Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies, and barriers in six countries","volume":"14","author":"Hammett","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.japh.2021.08.001_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health","volume":"60","author":"Lopez","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"Suppl 2","key":"10.1016\/j.japh.2021.08.001_bib23","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1093\/ofid\/ofz360.1143","article-title":"1280. A pharmacist-led PrEP program at the epicenter of the HIV epidemic in atlanta; our experience","volume":"6","author":"Smith","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.japh.2021.08.001_bib28","author":"Justia"},{"key":"10.1016\/j.japh.2021.08.001_bib29","author":"Text"},{"issue":"6","key":"10.1016\/j.japh.2021.08.001_bib30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.japh.2020.08.032","article-title":"Evaluation of naloxone furnishing community pharmacies in San Francisco","volume":"60","author":"Nguyen","year":"2020","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2021.08.001_bib31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.japh.2020.07.019","article-title":"Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies","author":"Chen","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2021.08.001_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/8755122516653611","article-title":"Drug information resources used by chain community pharmacists in Tennessee","volume":"32","author":"Borja-Hart","year":"2016","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.japh.2021.08.001_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/2050312118822927","article-title":"Grounded theory research: a design framework for novice researchers","volume":"7","author":"Chun Tie","year":"2019","journal-title":"SAGE Open Med"},{"issue":"4","key":"10.1016\/j.japh.2021.08.001_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ptdy.2020.03.017","article-title":"Implementing PrEP in the pharmacy","volume":"26","author":"Lopez","year":"2020","journal-title":"Pharm Today"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121003423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121003423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:49:56Z","timestamp":1761544196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121003423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1544319121003423"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.08.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}